1. Home
  2. EDUC vs SNGX Comparison

EDUC vs SNGX Comparison

Compare EDUC & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

SELL

Current Price

$0.87

Market Cap

8.9M

ML Signal

SELL

Logo Soligenix Inc.

SNGX

Soligenix Inc.

HOLD

Current Price

$0.22

Market Cap

7.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
SNGX
Founded
1965
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
7.6M
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
EDUC
SNGX
Price
$0.87
$0.22
Analyst Decision
Analyst Count
0
0
Target Price
N/A
★ $1.38
AVG Volume (30 Days)
33.8K
★ 161.2K
Earning Date
01-07-2027
11-06-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 142.86
57.03
EPS
★ N/A
N/A
Revenue
★ $22,913,600.00
$119,371.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.81
$0.23
52 Week High
$1.65
$3.39

Technical Indicators

Market Signals
Indicator
EDUC
SNGX
Relative Strength Index (RSI) 21.75 16.37
Support Level $0.81 N/A
Resistance Level $1.36 $0.82
Average True Range (ATR) 0.09 0.02
MACD 0.00 -0.01
Stochastic Oscillator 14.40 7.77

Price Performance

Historical Comparison
EDUC
SNGX

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie Segment.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Share on Social Networks: